Why did AXTI crash 16% today after a 95-fold surge in one year?

NEXT PICK · Market Insights

Why did AXTI crash 16% today after a 95-fold surge in one year?

Tuesday, June 16, 2026

A semiconductor small note that hovered around $1.72 last year surged to $143 within a year, with its market value swelling to about $6 billion, then gave back 15.98% in a single trading day today, closing at $93.04—this is why AXTI has surged onto the trending list today.

Even more glaring is the trigger point

Just as the stock price was approaching its all-time high, the company's CEO cashed out over $22 million, and the directors continued to reduce their holdings. As insiders start to leave, should the enthusiastic retail investors keep chasing, or should they pause and think?

Latest price $93.04 ▼ -15.98%

One-year gain Approx. +9500% ▲ Approaching historic highs

Analyst target average price $43.80 ▼ More than 50% lower than the current price

The seller of the "foundation of wafers" has caught the wave of AI optical communication

AXT doesn't make chips, but rather the most basic substrate beneath the chip—indium phosphide (InP), gallium arsenide (GaAs), germanium (Ge), and other compound semiconductor substrates—as well as raw materials like 6N+, 7N+ high-purity gallium and pBN crucibles, which are hard to replace.

For example, if optical modules, LiDAR, and VCSELs are high-rise buildings, AXT sells special cement for foundation casting. The foundation may seem inconspicuous, but it determines how tall and stable the entire building can be.

And this "foundation" happens to be right at the forefront of AI data centers. In the first quarter of 2026, the company's indium phosphide revenue will be $13.6 million, mainly driven by high-speed optical interconnect demand in data centers, with total revenue of $26.9 million, a year-on-year increase of 38.7%—this is the starting point of the market's frenzy about it.

What does 88 million in revenue support a 6 billion yuan market value, with a price-to-sales ratio close to 68 times—what does that mean?

Let's start with a set of contrasts

The company's fiscal year 2025 revenue is only $88.3 million, down 11% from $99.4 million in 2024, but its current market value is about $6 billion, corresponding to a price-to-sales ratio close to 68 times—while the typical range for compound semiconductor materials is only 5 to 15 times.

More importantly, it is the attitude of the analysts. The target average price offered by institutions covering the stock is only about $43.80, almost half the current price; The range ranges from B. Riley's $21 (sell) all the way to Northland's $125, with a surprisingly large divergence.

On the cash flow side, there was a turning point that research reports had underestimated: the company recently issued about 9.84 million shares at $64.25 per share, raising approximately $632.5 million. The risk of burning money was greatly alleviated, but the price was that existing shareholders were truly diluted.

So here's the question—when a company's market value is nearly 70 times its revenue and twice the analyst's price range, is the market buying in fundamentals, or is it just a narrative about AI?

Companies in the commercialization pilot phase were pre-priced by the market as growth champions

From a fundamental perspective, AXT is still in the commercialization pilot stage: mass production processes for InP, GaAs, and Ge substrates have been validated, and small-batch deliveries have been achieved for customers such as data centers, 5G, and LiDAR. Indium phosphide orders have exceeded $100 million, and the company plans to double its production capacity by the end of 2026.

But stock prices tell a different story. Its 200-day moving average is only about $37.6, while its current price is around $93, meaning the market has long priced it as the "champion of scale profitability," while the company's financial report still shows quarterly net losses.

A company in the pilot phase was preloaded with its growth valuation, and this gap is the root cause of today's correction.

Triple moat, yet simultaneously facing opponents with higher purity and stronger coverage

AXT's uniqueness lies in making domestic Chinese joint ventures (such as Tongmei and JinMei) vertically integrated from raw material purification to substrate processing, combined with export control barriers for key materials like InP, gallium, and germanium, forming a triple moat of technology, cost, and compliance.

Once downstream customers select substrate suppliers, switching requires re-process validation, which takes a long time and is costly. This natural switching cost further locks down its position.

But the moat is not without gaps. When it comes to ultra-high purity elements, 5N Plus almost monopolizes the market; In terms of epitaxial wafer technology and customer breadth, IQE is more mature; Japan's Sumitomo has about 1.5 times the production capacity of AXT in InP substrates. AXT excels in capacity scale and local supply chain integration, but is weak in cutting-edge purity and external links.

If the InP export bottleneck loosens further, it can capture more market share; But if competitors accelerate their production, how long can it hold its pricing power?

With a substrate market under $1 billion, can it fit a story worth $6 billion?

According to research reports, the global compound semiconductor substrate market was approximately 420 million USD in 2023, with indium phosphide accounting for about 150 million USD; By 2026, the overall Accessible Market (TAM) will be about $650 million, with AXT's truly high-end segment (SAM) serving about $280 million.

The growth direction is indeed attractive

Driven by 400G/800G optical modules, the compound annual growth rate of indium phosphide demand in the coming years is expected to be 28%–35%, with lidar and Micro LED also showing double-digit growth.

But on the flip side, a niche market with a total base of less than $1 billion is now about to fit into a company with a market value of about $6 billion—the gap between the ceiling and valuation will have to be filled sooner or later.

Demand, capacity, and arbitrage—these are the three cards held by the bulls

Those who read more often actually hold several heavier cards in hand:

▲ Bull Case

Insiders exited, valuations hanging low, and bearish reasons were equally strong

Every rebuttal from the bears hits a sore spot:

▼ Bear Case

Production capacity, financial reports, IPO: three observation windows for the second half of the year

In the following events, whoever cashes in first will control the next pace of the stock price:

• Doubling indium phosphide production capacity: The goal to be completed by the end of 2026 is the core test for achieving large-scale profitability
• Q2 2026 Financial Report: Company guidance per share is $0.06–0.08; if delivered, it will be a key jump from loss to profit
• China's InP export volume is expected to continue in the second half of 2026, which is likely to further ease global supply tightness and benefit gross margins
• Tongmei STAR Market IPO: Subsidiary listing process, impact direction is neutral to positive, timeframe not yet clear

From $1.70 to $143, then pullbacks after insiders cashed out

Over the past year, AXTI has charted a dizzying curve: from $1.72 to $143.16 over the 52-week range, its year-to-date gains reached about 95 times, transforming it from an overlooked small-cap stock into a star in the AI concept.

Supporting this round of celebration are the narrative of demand for indium phosphide substrates in AI data centers, as well as news about China's export easing; On June 12, Northland raised its AI-driven target price, adding fuel to the fire.

However, the CEO's large cash-out in early June became a turning point in sentiment, and combined with high valuations, the stock price then sharply pulled back, dropping nearly 16% today. The slow improvement in fundamentals has never caught up with the stock price spiraling out.

⚠️ Risk Notice What needs to be clearly seen is that AXT is still posting quarterly losses and negative net margins, yet its valuation has been pushed several times above the industry. Today's 16% plunge is precisely the result of this overdraft being corrected; Meanwhile, the company's revenue heavily depends on a few major clients. Key materials such as indium phosphide, gallium, and germanium remain under the shadow of geopolitics and export controls. Any tightening of these steps could impact the supply chain; Meanwhile, insiders' continuous sell-offs at high levels are an undeniable emotional signal. This article is an analysis based solely on publicly available information and does not constitute any investment advice. The market carries risks; decisions should be made based on your own judgment and personal responsibility for profits and losses.

🟡 Neutral Fundamentals are slowly improving, but valuations and insider share reductions have already overshadowed optimistic expectations.

💬 Discussion When insiders cash out, do you follow and add in the opposite trend?

Data source

• Real-time market cap and market cap (latest price $93.04, 52-week interval, market cap): [Investing.com — AXT Inc] (https://www.investing.com/equities/axt-inc), [MacroTrends market cap history]( https://www.macrotrends.net/stocks/charts/AXTI/axt-inc/market-cap)
• Today's movements and CEO cashing out, analyst target price ($43.80, range $21–$125): [CoinCentral — AXT slides 16% after CEO cashes out $22M]( https://coincentral.com/axt-axti-stock-slides-16-after-ceo-cashes-out-22-million-near-all-time-highs/)
• Q1 2026 Financial Report (Revenue $26.9M, +38.7%, EPS -$0.03, InP $13.6M, Order Book >$100 million, Capacity Doubled, Additional Fundraising $632.5M): [GuruFocus — AXTI Q1 2026] (https://www.gurufocus.com/news/8833441), [StockTitan — AXT 10-Q](https://www.stocktitan.net/sec-filings/AXTI/10-q-axt-inc-quarterly-earnings-report-5b8759ef200e.html)
• Analyst target upward and AI demand background: [StocksToTrade — AXTI Jumps As Northland Hikes Target] (https://stockstotrade.com/news/axt-inc-axti-news-20260612-2/)
• Business, moat, competitors, market size, valuation scenario: AXTI internal research report (2026-06-16) and company 10-K